SETD2 mutation and/or loss of the mark it writes, histone H3 lysine 36 trimethylation (H3K36me3), is linked to poor outcome and metastasis in ccRCC [2, 3]. Here, SETD2 is linked to nonpapillary renal cell carcinoma.